Trial Profile
The effect on embryo-quality of rLH-addition to rFSH for controlled ovarian hyperstimulation in women with poor ovarian reserve
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jan 2012
Price :
$35
*
At a glance
- Drugs Lutropin alfa (Primary) ; Recombinant follicle-stimulating hormone
- Indications Female infertility
- Focus Pharmacodynamics
- Acronyms L-AGE
- 01 Jan 2012 Results published in Human Reproduction.
- 14 May 2009 New trial record